Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Artigo Académico uri icon

autores

  • RUI MANUEL VIEIRA REIS
  • Silva-Oliveira RJ
  • Silva VA
  • Martinho O
  • Cruvinel-Carloni A
  • Melendez ME
  • Rosa MN
  • de Paula FE
  • Aksoy-Aksel, A.

data de publicação

  • fevereiro 1, 2016